These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 3335192)
1. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations]. Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)]. Gottschalk B; Wiesemann HG; Stephan U Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230 [TBL] [Abstract][Full Text] [Related]
3. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? Lankisch PG; Lembcke B; Göke B; Creutzfeldt W Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109 [TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis. Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983 [TBL] [Abstract][Full Text] [Related]
6. [Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea]. Kölbel C; Layer P; Hotz J; Goebell H Med Klin (Munich); 1986 Feb; 81(3):85-6. PubMed ID: 3641037 [No Abstract] [Full Text] [Related]
7. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin. Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419 [TBL] [Abstract][Full Text] [Related]
8. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity. Pap A; Varró V Hepatogastroenterology; 1988 Apr; 35(2):83-6. PubMed ID: 3371850 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin]. Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Dutta SK; Rubin J; Harvey J Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746 [TBL] [Abstract][Full Text] [Related]
11. Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea. Lembcke B; Grimm K; Lankisch PG Am J Gastroenterol; 1987 Jun; 82(6):526-31. PubMed ID: 3646827 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038 [TBL] [Abstract][Full Text] [Related]
14. [Steatorrhea and its treatment with pancreatic enzymes in endocrine tumors of the pancreas (pancreatic adenomas)]. Varas MJ; López A Rev Esp Enferm Dig; 1990 Jul; 78(1):27-30. PubMed ID: 1701657 [TBL] [Abstract][Full Text] [Related]
15. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study. Gouerou H; Dain MP; Parrondo I; Poisson D; Bernades P Int J Pancreatol; 1989; 5 Suppl():45-50. PubMed ID: 2702250 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages. Ansaldi-Balocco N; Santini B; Sarchi C J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938 [TBL] [Abstract][Full Text] [Related]
17. Medical treatment of pancreatic insufficiency. DiMagno EP Mayo Clin Proc; 1979 Jul; 54(7):435-42. PubMed ID: 36518 [TBL] [Abstract][Full Text] [Related]
18. Controversies in the treatment of exocrine pancreatic insufficiency. DiMagno EP Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479 [No Abstract] [Full Text] [Related]
19. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency. Zerega J; Lerner S; Meyer JH Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697 [TBL] [Abstract][Full Text] [Related]
20. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts. Graham DY N Engl J Med; 1977 Jun; 296(23):1314-7. PubMed ID: 16212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]